Cellect Biotechnology Ltd.

NASDAQ: APOPHealthcare / Biotechnology / Israel
0.5200+0.0100+1.96%Vol 73 7771Y Perf -92.84%
Jul 22nd, 2019 15:22
BID0.4900 ASK0.5200
Open0.5000 Previous Close0.5100
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.00 
Analyst Rating
— 0.00
Potencial %
2 207.69 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)6 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.73 
Earnings Date
8th Aug 2019

Today's Price Range

0.48000.5200

52wk Range

0.47007.34

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.00%
1 Month
-8.77%
3 Months
-40.91%
6 Months
-82.07%
1 Year
-92.84%
3 Years
-
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
APOP0.52000.01001.96
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.16-
Q04 2018--0.16-
Q03 2018-0.28-0.29-3.57
Q02 2018-0.29-0.2610.34
Q01 2018-0.30-0.1646.67
Q04 2017-0.31-0.1648.39
Q03 2017-0.30-0.39-30.00
Q02 2017-0.22-0.23-4.55
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.36-24.14Negative
12/2018 FY-1.07-9.18Negative
3/2019 QR-0.33-6.45Negative
12/2019 FY-1.228.27Positive
Next Report Date8th Aug 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume73 777
Shares Outstanding (in ths.)11 204
Trades Count54
Dollar Volume37 520
Avg. Volume198 596
Avg. Weekly Volume27 295
Avg. Monthly Volume44 519
Avg. Quarterly Volume66 266
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd is a biotechnology company engaged in developing a novel technology platform. The company is engaged in the development of an innovative, unique technology that enables the biological filtering and commercialization of stem cells.

CEO: Shai Yarkoni

Teplephone: +972 99741444

Address: 23 Hata'as Street, Kfar Saba 44425, , ISR

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

33%67%

Bearish Bullish

75%25%

Bearish Bullish

52%48%

Bearish Bullish

52%48%

News